SuperSonic Imagine Reports Revenue Growth of 6% in H1 2019

Regulatory News:

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialized in ultrasound medical imaging (ultrasound), today announces its revenue for the first half of 2019.

Michèle Lesieur, Chief Executive Officer of SuperSonic Imagine, comments: “The second quarter was marked by the offer received by the Hologic group with a view to acquiring 100% of SuperSonic Imagine’s capital for a price of 1.50 euros per share. This contemplated acquisition of Supersonic Imagine by Hologic meets all our strategic objectives, and would allow us to develop the Ultrasound activity within a group that shares our values. From an operational standpoint, China is continuing to drive SuperSonic Imagine’s growth with a further very buoyant increase in sales, while the United States recorded a first half below expectations”.

In thousands of euros	2019	2018	Change (%)
Products	5,122	4,213	+22%
% of total sales	85%	84%
Services	916	817	+12%
% of total sales	15%	16%
1st quarter sales	6,038	5,030	+20%
Products	4,783	5,274	-9%
% of total sales	83%	86%
Services	972	877	+11%
% of total sales	17%	14%
2nd quarter sales